Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-α)in Slovenia

Hepato-Gastroenterology

Volumn 49, Issue 47, 2002, Pages 1320-1325

  Brinovec, Vladimir ^a   Lešnicar, Gorazd ^a   Maticic, Mojca ^a   Meglic Volkar, Jelka ^a   Poljak, Mario ^a   Seme, Katja ^a   Ferlan Marolt, Vera ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Chronic hepatitis C; Interferon ; Long term follow up; Treatment

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GENOTYPE; HAIR LOSS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; PRIORITY JOURNAL; SARCOIDOSIS; SKIN ULCER; SLOVENIA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD; VIRUS TYPING;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SLOVENIA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0036377954     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Our experience in treatment of chronic hepatitis C with recombinant interferon alpha
2. Clinical outcomes after transfusion-associated hepatitis C
3. EASL International Consensus Conference on Hepatitis C. Paris, 26-28 February 1999. Consensus Statement
4. Frequency and consequences of acute hepatitis non A, non B (hepatitis C) in Slovenia
5. Randomized trial comparing three different regimens of alpha-21-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group
6. Interferon alfa-2b for chronic hepatitis C: Effects of dose increments and duration of treatment on response rates. Results of the first multicentre Australian trial
7. Management of hepatitis C
8. A French consensus conference on hepatitis C: Screening and treatment
9. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
10. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
11. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
12. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C
13. Randomised trial of interferon α-2b plus ribavirin for 48 weeks versus interferon α-2b placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
14. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
15. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
16. Formulation and application of a numerical scoring system for assessing histolytical activity in asymptomatic chronic active hepatitis
17. Classification of chronic viral hepatitis: A need for reassessment
18. Clinical and histological aspects of chronic HCV infection and cirrhosis
19. Chronic hepatitis. An update on terminology and reporting
20. An algorithm for the grading of activity in chronic hepatitis C
21. Standardization of pathohistological diagnosis in hepatology
22. Hospital acquired infection with hepatitis non A, non B viruses
23. Preliminary results from the study of acute hepatitis non A non B (hepatitis C)
24. Hepatitis non A non B in the light of new findings and results of anti-hepatitis C virus testings
25. Chronic hepatitis C
26. Chronic hepatitis C and interferon alpha. Conventional and cumulative meta-analyses of randomized controlled trials
27. Viral hepatitis
28. Future directions in the treatment of patients with chronic hepatitis C virus infection
29. How soon can a virological sustained response be determined after withdrawal of interferon therapy in chornic hepatitis C?
30. Natural history of liver fibrosis progression in patients with chronic hepatitis C
31. Distribution of hepatitis C virus genotypes in Slovenia
32. Hepatitis C. Virus RNA as a predictor of a long-term response to interferon-α therapy
33. Sarcoidosis in a patient with chronic hepatitis C treated with interferon α - Case report